Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems

Background. Innovative drugs targeting the PD1/PD-L1 axis have opened promising scenarios in modern cancer therapy. Plenty of assays and scoring systems have been developed for the evaluation of PD-L1 immunohistochemical expression, so far considered the most reliable therapeutic predictive marker....

Descripción completa

Detalles Bibliográficos
Autores principales: Marletta, Stefano, Fusco, Nicola, Munari, Enrico, Luchini, Claudio, Cimadamore, Alessia, Brunelli, Matteo, Querzoli, Giulia, Martini, Maurizio, Vigliar, Elena, Colombari, Romano, Girolami, Ilaria, Pagni, Fabio, Eccher, Albino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321150/
https://www.ncbi.nlm.nih.gov/pubmed/35887569
http://dx.doi.org/10.3390/jpm12071073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321150/
https://www.ncbi.nlm.nih.gov/pubmed/35887569
http://dx.doi.org/10.3390/jpm12071073

Ejemplares similares